You are here » Home » Companies » Company Overview » Ajooni Biotech Ltd

Ajooni Biotech Ltd.

BSE: 535040 Sector: Others
NSE: AJOONI ISIN Code: INE820Y01013
BSE 05:30 | 01 Jan Ajooni Biotech Ltd
NSE 00:00 | 27 May 55.65 1.30
(2.39%)
OPEN

54.55

HIGH

56.30

LOW

54.40

OPEN
PREVIOUS CLOSE
VOLUME
52-Week high 0.00
52-Week low 0.00
P/E
Mkt Cap.(Rs cr) 0
Buy Price
Buy Qty
Sell Price
Sell Qty
OPEN
CLOSE
VOLUME
52-Week high 0.00
52-Week low 0.00
P/E
Mkt Cap.(Rs cr) 0
Buy Price
Buy Qty
Sell Price
Sell Qty

Ajooni Biotech Ltd. (AJOONI) - Chairman Speech

Company chairman speech

FROM THE DESK OF THE CHAIRMAN

Mr. Jasjot Singh Chairman cum Managing Director

Dear Shareholders

I hope you and your families are safe and healthy.

I am delighted to share with you the events and developments of your Company during thecourse of the financial year 2020-21.

Financial Year 2020-21 was one of the toughest years due to the COVID-19 pandemic andhas led to many challenges. With a nation-wide lockdown at the beginning of the year yourcompany quickly adapted to this situation and immediate approached the state government todeclare animal feed as an essential commodity and its plant became operational with in aweek's time of lockdown after obtaining all regulatory approvals and during the entirelockdown period we managed to maintained the supply chain & other logisticsuninterrupted to the satisfaction of our customers and suppliers while adoption of allhealth protocol announced by the government.

The year gone-by was representative of the value created for all its stakeholders.Business growth through competitively growing your Company's core business of Animal Feedby entering into long term agreements /association with leading MNC engaged in thebusiness of dairy and animal health care products.

A new modern plant of Feed is setup and commenced commercial production in spite ofadverse business environment due to pandemic. The focus on R&D continues with thesetting up a new state-of the-art R&D facility at Plant site which will help us inimproving our product quality and cost optimising in long run. Best human resources areengaged to offer best product and services to our customers.

The fiscal year 2020-21 was an excellent year for Ajooni Biotech Ltd in terms ofbusiness growth. The turnover has increased 21.56 % and profit before tax for the yearrepresenting year-on-year growth of 4.7 %.

The business is doing well with new product launches and expanding its customer base.Your Company believes in inclusive growth that aims at enhancing the competitiveness ofthe businesses while simultaneously advancing the economic and social conditions of thecommunities in which it operates.

We believe that there is a good potential for Feed Supplement business. Looking at thisopportunity we started efforts to develop new and unique animal health care products andI am confident that this new business will generate good profits and create overall valueto all the Stakeholders.

We are confident of achieving our long term objectives of inclusive sustainable andprofitable growth. As we look ahead I feel confident of strong growth in the medium tolong term which will enable us to improve our performance further and create greatershareholder value.

I would like to take this opportunity to thank all our employees for their contributionin the continued success of Ajooni.

I would also like to extend my gratitude towards our business partners associatesvendors and also the bankers and government agencies for their continued support.

I would also like to express my sincere appreciation to all of our Shareholders fortheir faith trust encouragement and support.

Yours sincerely
Jasjot Singh
Chairman cum Managing Director

.